Abstract
Current management guidelines for lupus nephritis (LN) do not attach importance to histological indices of disease activity or chronicity. The present study was performed to evaluate the clinical relevance of these indices in determining outcomes in patients with class IV LN. We analyzed the data of all patients with biopsy-proven class IV LN seen over a 6-year period. The histopathological findings were reviewed; the activity and chronicity indices proposed by Austin [AI (Austin) & CI (Austin)] and the renal biopsy index proposed by Hill were calculated. As immunofluorescence was not done in all patients, this was excluded from calculation of the renal biopsy index, which was referred to as the modified Hill’s index (MHI), which was a composite of glomerular activity index (GAI), chronicity index (CI) and tubulo-interstitial activity index (TIAI). Pearson’s correlation coefficient, multilinear regression analysis and logistic analysis were performed, and p value of <.05 was considered significant. During the study period, 114 cases of LN were evaluated, of which 64 % (73/114) had class IV LN. The mean age was 26.5 years, and 92 % were females. The mean scores of AI (Austin), CI (Austin), GAI, CI, TIAI and MHI were 8.46, 2.50, 7.54, 3.06, 4.74 and 2.23, respectively. Serum creatinine correlated significantly with TIAI, CI, CI (Austin) as well as MHI, but not with AI (Austin) or GAI. The serum creatinine level was the strongest clinical parameter determining outcome, while none of the histological indices correlated with either treatment outcome or mortality. None of the histological indices performed better than serum creatinine level in determining the treatment outcomes and mortality.
Similar content being viewed by others
References
Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, Drosos AA, Moutpoulos HM (1993) Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus 2:303–312
Wallace DJ, Podell TE, Weiner JM, Cox MB, Klinenberg JR, Forouzesh S et al (1982) Lupus nephritis: experience with 230 patients in a private practice from 1950 to 1980. Am J Med 72:209–220
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. The european working party on systemic lupus erythematosus. Medicine (Baltimore) 72:113–124
Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250
Giannakakis K, Faraggiana T (2011) Histopathology of lupus nephritis. Clin Rev Allergy Immunol 40:170–180
Wu LH, Yu F, Tan Y, Qu Z, Chen MH, Wang SX et al (2013) Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int 83:715–723
Kojo S, Sada K, Kobayashi M, Maruyama M, Maeshima Y, Sugiyama H et al (2009) Clinical usefulness of a prognostic score in histological analysis of renal biopsy in patients with lupus nephritis. J Rheumatol 36:2218–2223
Giannico G, Fogo AB (2013) Lupus nephritis: is kidney biopsy currently necessary in the management of lupus nephritis? Clin J Am Soc Nephrol 8:138–145
Pirani CL, Pollak VE, Schwartz FD (1964) The reproducibility of semiquantitative analysis of renal histology. Nephron 29:230–237
Morel-Maroger L, Mery JP, Droz D, Godin M, Verroust P, Kourilsky O et al (1976) The course of lupus nephritis: contribution of serial renal biopsies. Adv Nephrol Necker Hosp 6:79–118
Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689–695
Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ (1993) Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 21:374–377
Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D (1987) Long-term follow-up of lupus nephritis: a study based on the classification of the world health organization. Am J Med 83:877–885
Hill GS, Delahousse M, Nochy D, Tomkiewicz E, Rémy P, Mignon F et al (2000) A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 58:1160–1173
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al (2003) The Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc 289:2560–2571
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139–274
Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45:544–550
Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE (1995) High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 10:1620–1628
Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JHM, Swaak TJG (1990) Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum 33:970–977
Esdaile JM, Federgreen W, Quintal H, Suissa S, Hayslett JP, Kashgarian M (1991) Predictors of one year outcome in lupus nephritis: the importance of renal biopsy. Q J Med 81:907–918
Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R et al (2005) Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology (Carlton) 10:504–510
Appel GB, Silva FG, Pirani CL (1978) Renal involvement in systemic lupus erythematosus: a study of 56 patients emphasizing histologic classification. Medicine (Baltimore) 57:371–410
Banfi G, Mazzucco G, Barbiano di Belgiojoso G, Bestetti Bosisio M, Stratta P, Confalonieri R et al (1985) Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome. Q J Med 55:153–168
Donadio JV, Hart GM, Bergstralh EJ, Holley KF (1995) Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 4:109–115
Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL) (1992) Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Am J Kidney Dis 19:473–479
Liang L, Yang X, Xu H, Zhan Z, Ye Y, Yu X et al (2004) Clinical predictors of recovery and complications in the management of recent-onset renal failure in lupus nephritis: a chinese experience. J Rheumatol 31:701–706
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rathi, M., Gupta, K.L., Joshi, K. et al. Histopathological indicators of disease outcome in class IV lupus nephritis: a revisit of various indices. Rheumatol Int 35, 1511–1517 (2015). https://doi.org/10.1007/s00296-015-3240-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-015-3240-2